Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

Cancer Cell. 2003 Jul;4(1):13-8. doi: 10.1016/s1535-6108(03)00165-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Cycle / drug effects
  • Cell Differentiation / drug effects
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology*
  • Gene Expression Regulation, Neoplastic*
  • Histone Deacetylase Inhibitors*
  • Histone Deacetylases / metabolism
  • Histones / metabolism
  • Humans
  • Neoplasms / drug therapy*
  • Transcription, Genetic*

Substances

  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Histones
  • Histone Deacetylases